IMEGX
Price
$23.50
Change
+$0.18 (+0.77%)
Updated
Sep 16 closing price
Net Assets
N/A
VEMRX
Price
$113.63
Change
+$0.86 (+0.76%)
Updated
Sep 16 closing price
Net Assets
130.49B
Interact to see
Advertisement

IMEGX vs VEMRX

Header iconIMEGX vs VEMRX Comparison
Open Charts IMEGX vs VEMRXBanner chart's image
Macquarie Systematic Em Mkts Eq R6
Price$23.50
Change+$0.18 (+0.77%)
VolumeN/A
Net AssetsN/A
Vanguard Emerging Mkts Stock Idx InsPlus
Price$113.63
Change+$0.86 (+0.76%)
VolumeN/A
Net Assets130.49B
IMEGX vs VEMRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
IMEGX vs. VEMRX commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMEGX is a StrongBuy and VEMRX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
IMEGX pays higher dividends than VEMRX: IMEGX (3.12) vs VEMRX (2.70). IMEGX was incepted earlier than VEMRX: IMEGX (11 years) vs VEMRX (15 years). IMEGX (1.11) is less costly to investors than VEMRX (0.07). IMEGX is a more actively managed with annual turnover of: 28.00 vs. VEMRX (8.00). VEMRX annual gain was more profitable for investors over the last year : 22.75 vs. IMEGX (20.62). VEMRX return over 5 years is better than : 33.37 vs. IMEGX (7.11).
IMEGXVEMRXIMEGX / VEMRX
Total Expense Ratio0.650.07929%
Annual Report Gross Expense Ratio1.110.071,586%
Fund Existence11 years15 years-
Gain YTD20.33021.56894%
Front LoadN/AN/A-
Min. Initial InvestmentN/A100000000-
Min. Initial Investment IRAN/AN/A-
Net AssetsN/A130B-
Annual Yield % from dividends3.122.70116%
Returns for 1 year20.6222.7591%
Returns for 3 years29.0845.5864%
Returns for 5 years7.1133.3721%
Returns for 10 years84.8783.46102%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SKY77.972.69
+3.57%
Champion Homes Inc
TIPT24.200.50
+2.11%
Tiptree
IPHA2.08N/A
+0.19%
Innate Pharma SA
IRIX1.28N/A
N/A
IRIDEX Corp
EXC42.73-0.70
-1.61%
Exelon Corp